Notable companies
The most notable companies in this group are Eli Lilly & Co (null:LLY), Johnson & Johnson (null:JNJ), Merck & Co (null:MRK), Pfizer (null:PFE), Bristol-Myers Squibb Co (null:BMY), ZOETIS (null:ZTS), Elanco Animal Health (null:ELAN), Intra-Cellular Therapies (null:ITCI).
Industry description
The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
Market Cap
The average market capitalization across the iShares US Pharmaceuticals ETF ETF is 55.87B. The market cap for tickers in the group ranges from 221.06M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is AMLX at 221.06M.
High and low price notable news
The average weekly price growth across all stocks in the iShares US Pharmaceuticals ETF ETF was -1%. For the same ETF, the average monthly price growth was -1%, and the average quarterly price growth was 8%. AMLX experienced the highest price growth at 12%, while AXSM experienced the biggest fall at -10%.
Volume
The average weekly volume growth across all stocks in the iShares US Pharmaceuticals ETF ETF was 3%. For the same stocks of the ETF, the average monthly volume growth was -12% and the average quarterly volume growth was -20%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 57
P/E Growth Rating: 64
Price Growth Rating: 51
SMR Rating: 72
Profit Risk Rating: 66
Seasonality Score: 22 (-100 ... +100)